Gastrointestinal Carcinogenesis and Therapeutics

Gastrointestinal (GI) tumours are the second most regular tumours analysed in both women and men in North America. Out of all gastrointestinal tumours the most widely recognized one is colorectal growth and the one among recently analysed gastrointestinal malignancies and pancreatic ductal adenocarcinoma is the lethal one because of absence of early diagnosis and constrained achievement of systemic treatment.

  • Development of Gastrointestinal Carcinogenesis and Therapeutics
  • Diagnosis and Treatment of Gastrointestinal Carcinogenesis
  • Current trends and recent advances in the treatment of Gastrointestinal Carcinogenesis and Therapeutics
  • Hepatobillary Carcinogesesis and Therapeutics
  • Pancreatic ductal Carcinogenesis and Therapeutics
  • Colorectal Carcinogenesis and Therapeutics

Related Conference of Gastrointestinal Carcinogenesis and Therapeutics

October 16-18, 2017

2nd World Summit on Metabolic Disorders

Chicago, Illinois, USA
December 07-08, 2017

2nd International Conference on Digestive Diseases

Madrid, Spain
December 14-15, 2017

11th World Gastroenterologists Summit

Dubai, UAE
March 15-16, 2018

12th Global
Gastroenterologists Meeting

Barcelona, Spain
April 09-10, 2018

12th International Conference on Abdominal Imaging and Endoscopy

Amsterdam, Netherlands
April 09-11, 2018

6th World Congress on Hepatitis & Liver Diseases

Amsterdam, Netherlands
May 28-29, 2018

6th International Conference on Hepatology

Osaka, Japan
August 02-04, 2018

13th Euro-Goblal Gastroenterology Conference

Barcelona, Spain
September 17-18, 2018
10 Plenary Forums - 1Event

3rd International Conference on Hepatobiliary & Pancreatic Disorders
(10 Plenary Forums - 1Event)

Philadelphia, Pennsylvania
Oct 22-23, 2018

World Summit on Liver Cirrhosis and Hepatitis

Osaka, Japan

Gastrointestinal Carcinogenesis and Therapeutics Conference Speakers